Sampling port for real-time analysis of bioaerosol in whole body exposure system for animal aerosol model development

Journal of Pharmacological and Toxicological Methods

Volumn 63, Issue 2, 2011, Pages 143-149

  Saini, Divey ^a   Hopkins, Gregory W ^a   Chen, Ching Ju ^a   Seay, Sarah A ^a   Click, Eva M ^a   Lee, Sunhee ^a   Hartings, Justin M ^b   Frothingham, Richard ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Biaera Technologies   (United States)

Author keywords

Animal models; Bacillus anthracis; Bioaerosol; Diameter; Dosimetry; Inhalation; Methods; Mycobacterium tuberculosis; Sampling; Yersinia pestis

Indexed keywords

AIRBORNE BACTERIUM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL COUNT; BACTERIAL VIABILITY; BACTERIUM ISOLATION; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXPERIMENTAL MODEL; INOCULATION; LUNG HOMOGENATE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PARTICLE SIZE; SAMPLING; YERSINIA PESTIS;

AEROSOLS; AIR PRESSURE; ANIMALS; ATMOSPHERE EXPOSURE CHAMBERS; EQUIPMENT DESIGN; HUMIDITY; INHALATION EXPOSURE; MICE; MICE, INBRED C57BL; MICROBIAL VIABILITY; MODELS, ANIMAL; PARTICLE SIZE; TEMPERATURE;

ANIMALIA; BACILLUS ANTHRACIS; MUS; MYCOBACTERIUM TUBERCULOSIS; YERSINIA PESTIS;

EID: 79951811084     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2010.09.002     Document Type: Article

References (23)

1. Agar S.L., Sha J., Foltz S.M., Erova T.E., Walberg K.G., Parham T.E., et al. Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92. Microbiology 2008, 154(Pt 7):1939-1948.
2. Baker Manual Operating and Maintenance Manual for IsoGARD Isolator S/N 89357 2006.
3. Baron P.A., Willeke K. Aerosol Measurement: Principles, Techniques, and Applications 2001, Wiley-Interscience.
4. Basaraba R.J., Smith E.E., Shanley C.A., Orme I.M. Pulmonary lymphatics are primary sites of mycobacterium tuberculosis infection in guinea pigs infected by aerosol. Infection and Immunity 2006, 74(9):5397-5401.
5. Brown J.S., Wilson W.E., Grant L.D. Dosimetric comparisons of particle deposition and retention in rats and humans. Inhalation Toxicology 2005, 17(7-8):355-385.
6. Ching-Wen C., Grinshpun S.A., Willeke K., Macher J.M., Donnelly J., Clark S., et al. Factors affecting microbiological colony count accuracy for bioaerosol sampling and analysis. American Industrial Hygiene Association Journal 1995, 56(10):979-986.
7. Cox C.S., Wathes C.M. Bioaerosols Handbook 1995, CRC Lewis Publishers, Boca Raton, FL.
8. Guyton A. Analysis of respiratory patterns in laboratory animals. The American Journal of Physiology 1947, 150(1):78-83.
9. Hairston P.P., Ho J., Quant F.R. Design of an instrument for real-time detection of bioaerosols using simultaneous measurement of particle aerodynamic size and intrinsic fluorescence. Journal of Aerosol Science 1997, 28(3):471-482.
10. Hartings J.M., Roy C.J. The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates. Journal of Pharmacological and Toxicological Methods 2004, 49(1):39-55.
11. Heine H.S., Bassett J., Miller L., Hartings J.M., Ivins B.E., Pitt M.L., et al. Determination of antibiotic efficacy against bacillus anthracis in a mouse aerosol challenge model. Antimicrobial Agents and Chemotherapy 2007, 51(4):1373-1379.
12. Hinds W.C. Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles 1999, Wiley-Interscience.
13. Inglesby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., Friedlander A.M., et al. Anthrax as a biological weapon: medical and public health management. JAMA 1999, 281(18):1735-1745.
14. Kim S., Ramakrishnan M., Raynor P., Goyal S. Effects of humidity and other factors on the generation and sampling of a coronavirus aerosol. Aerobiologia 2007, 23(4):239-248.
15. Marthi B., Fieland V.P., Walter M., Seidler R.J. Survival of bacteria during aerosolization. Applied and Environmental Microbiology 1990, 56(11):3463-3467.
16. Nuermberger E.L., Yoshimatsu T., Tyagi S., Bishai W.R., Grosset J.H. Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG. Infection and Immunity 2004, 72(2):1065-1071.
17. Peterson J.W., Comer J.E., Baze W.B., Noffsinger D.M., Wenglikowski A., Walberg K.G., et al. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model. Infection and Immunity 2007, 75(7):3414-3424.
18. Schmid O., Bolle I., Harder V., Karg E., Takenaka S., Schulz H., et al. Model for the deposition of aerosol particles in the respiratory tract of the rat. I. Nonhygroscopic particle deposition. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2008, 21(3):291-307.
19. Stone R.C., Johnson D.L. A note on the effect of nebulization time and pressure on the culturability of Bacillus subtilis and Pseudomonas fluorescens. Aerosol Science and Technology 2002, 36(5):536-539.
20. Swearengen J.R. Biodefense: Research Methodology and Animal Models 2005, CRC Press.
21. Tobias H.J., Schafer M.P., Pitesky M., Fergenson D.P., Horn J., Frank M., et al. Bioaerosol mass spectrometry for rapid detection of individual airborne. Applied and Environmental Microbiology 2005, 71(10):6086-6095.
22. Welkos S.L., Keener T.J., Gibbs P.H. Differences in susceptibility of inbred mice to Bacillus anthracis. Infection and Immunity 1986, 51(3):795-800.
23. Yoon K.-Y., Byeon J.H., Park J.-H., Ji J.H., Bae G.N., Hwang J. Antimicrobial characteristics of silver aerosol nanoparticles against Bacillus subtilis bioaerosols. Environmental Engineering Science 2008, 25(2):289-294.